13 results
10-K
2020 FY
LTRN
Lantern Pharma Inc
10 Mar 21
Annual report
4:07pm
, Chief Administrative Officer, General Counsel and Secretary of BioNumerik and has a minority ownership interest in BioNumerik. The Assignment … , Chief Administrative Officer, General Counsel and Secretary of BioNumerik and has a minority ownership interest in BioNumerik. Nothing was expensed
424B4
LTRN
Lantern Pharma Inc
15 Jan 21
Prospectus supplement with pricing info
5:24pm
, Chief Administrative Officer, General Counsel and Secretary of BioNumerik and has a minority ownership interest in BioNumerik. The Assignment Agreement … , a member of our board of directors, (iii) BMI, an entity (a) in which Dr. Silberstein, our director, owns a minority interest and serves as a director
DRS
d3rpskyzaztjk5p8djbc
16 Dec 20
Draft registration statement
12:00am
10-Q
s0pr3jj7nzteztvdr
30 Jul 20
Quarterly report
6:30am
424B4
y352 lb3hnkoc
12 Jun 20
Prospectus supplement with pricing info
7:49am
S-1
zln mf003rwcq9opc2n
16 Apr 20
IPO registration
3:32pm
DRS
5ry4r
24 Jan 20
Draft registration statement
12:00am
- Prev
- 1
- Next